BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 25477533)

  • 1. Molecular pathways: cbl proteins in tumorigenesis and antitumor immunity-opportunities for cancer treatment.
    Liyasova MS; Ma K; Lipkowitz S
    Clin Cancer Res; 2015 Apr; 21(8):1789-94. PubMed ID: 25477533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of function Cbl-c mutations in solid tumors.
    Daniels SR; Liyasova M; Kales SC; Nau MM; Ryan PE; Green JE; Lipkowitz S
    PLoS One; 2019; 14(7):e0219143. PubMed ID: 31260484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flt3-dependent transformation by inactivating c-Cbl mutations in AML.
    Sargin B; Choudhary C; Crosetto N; Schmidt MHH; Grundler R; Rensinghoff M; Thiessen C; Tickenbrock L; Schwäble J; Brandts C; August B; Koschmieder S; Bandi SR; Duyster J; Berdel WE; Müller-Tidow C; Dikic I; Serve H
    Blood; 2007 Aug; 110(3):1004-12. PubMed ID: 17446348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis.
    Sévère N; Dieudonné FX; Marie PJ
    Cell Death Dis; 2013 Jan; 4(1):e463. PubMed ID: 23328670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies.
    Lv K; Jiang J; Donaghy R; Riling CR; Cheng Y; Chandra V; Rozenova K; An W; Mohapatra BC; Goetz BT; Pillai V; Han X; Todd EA; Jeschke GR; Langdon WY; Kumar S; Hexner EO; Band H; Tong W
    Genes Dev; 2017 May; 31(10):1007-1023. PubMed ID: 28611190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of c-Cbl E3 ubiquitin ligase activity enhances the development of myeloid leukemia in FLT3-ITD mutant mice.
    Taylor SJ; Thien CB; Dagger SA; Duyvestyn JM; Grove CS; Lee BH; Gilliland DG; Langdon WY
    Exp Hematol; 2015 Mar; 43(3):191-206.e1. PubMed ID: 25534201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cbl family proteins: ring leaders in regulation of cell signaling.
    Swaminathan G; Tsygankov AY
    J Cell Physiol; 2006 Oct; 209(1):21-43. PubMed ID: 16741904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CBL exon 8/9 mutants activate the FLT3 pathway and cluster in core binding factor/11q deletion acute myeloid leukemia/myelodysplastic syndrome subtypes.
    Reindl C; Quentmeier H; Petropoulos K; Greif PA; Benthaus T; Argiropoulos B; Mellert G; Vempati S; Duyster J; Buske C; Bohlander SK; Humphries KR; Hiddemann W; Spiekermann K
    Clin Cancer Res; 2009 Apr; 15(7):2238-47. PubMed ID: 19276253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ubiquitin Ligases c-Cbl and Cbl-b Negatively Regulate Platelet-derived Growth Factor (PDGF) BB-induced Chemotaxis by Affecting PDGF Receptor β (PDGFRβ) Internalization and Signaling.
    Rorsman C; Tsioumpekou M; Heldin CH; Lennartsson J
    J Biol Chem; 2016 May; 291(22):11608-18. PubMed ID: 27048651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E3 ubiquitin ligase Cbl-b in innate and adaptive immunity.
    Liu Q; Zhou H; Langdon WY; Zhang J
    Cell Cycle; 2014; 13(12):1875-84. PubMed ID: 24875217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malfunctions within the Cbl interactome uncouple receptor tyrosine kinases from destructive transport.
    Dikic I; Schmidt MHH
    Eur J Cell Biol; 2007 Sep; 86(9):505-12. PubMed ID: 17553592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cbl-b negatively regulates B cell antigen receptor signaling in mature B cells through ubiquitination of the tyrosine kinase Syk.
    Sohn HW; Gu H; Pierce SK
    J Exp Med; 2003 Jun; 197(11):1511-24. PubMed ID: 12771181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel oncogenic mutations of CBL in human acute myeloid leukemia that activate growth and survival pathways depend on increased metabolism.
    Fernandes MS; Reddy MM; Croteau NJ; Walz C; Weisbach H; Podar K; Band H; Carroll M; Reiter A; Larson RA; Salgia R; Griffin JD; Sattler M
    J Biol Chem; 2010 Oct; 285(42):32596-605. PubMed ID: 20622007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases.
    Mohapatra B; Ahmad G; Nadeau S; Zutshi N; An W; Scheffe S; Dong L; Feng D; Goetz B; Arya P; Bailey TA; Palermo N; Borgstahl GE; Natarajan A; Raja SM; Naramura M; Band V; Band H
    Biochim Biophys Acta; 2013 Jan; 1833(1):122-39. PubMed ID: 23085373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation.
    Peschard P; Ishiyama N; Lin T; Lipkowitz S; Park M
    J Biol Chem; 2004 Jul; 279(28):29565-71. PubMed ID: 15123609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling.
    Kang JM; Park S; Kim SJ; Hong HY; Jeong J; Kim HS; Kim SJ
    Oncogene; 2012 Dec; 31(50):5123-31. PubMed ID: 22310290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative regulation of receptor tyrosine kinases by ubiquitination: Key roles of the Cbl family of E3 ubiquitin ligases.
    Tang R; Langdon WY; Zhang J
    Front Endocrinol (Lausanne); 2022; 13():971162. PubMed ID: 35966060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Casitas B-lineage lymphoma mutants activate AKT to induce transformation in cooperation with class III receptor tyrosine kinases.
    Polzer H; Janke H; Schmid D; Hiddemann W; Spiekermann K
    Exp Hematol; 2013 Mar; 41(3):271-80.e4. PubMed ID: 23127761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulated intracellular signaling by mutated c-CBL in myeloid neoplasms.
    Ogawa S; Shih LY; Suzuki T; Otsu M; Nakauchi H; Koeffler HP; Sanada M
    Clin Cancer Res; 2010 Aug; 16(15):3825-31. PubMed ID: 20547695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Cbl and Cbl-b ligases mediate 17-allylaminodemethoxygeldanamycin-induced degradation of autophosphorylated Flt3 kinase with internal tandem duplication through the ubiquitin proteasome pathway.
    Oshikawa G; Nagao T; Wu N; Kurosu T; Miura O
    J Biol Chem; 2011 Sep; 286(35):30263-30273. PubMed ID: 21768087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.